DOPAMINE DEFICIENCY IN A GENETIC MOUSE MODEL OF LESCH-NYHAN DISEASE

被引:0
|
作者
JINNAH, HA
WOJCIK, BE
HUNT, M
NARANG, N
LEE, KY
GOLDSTEIN, M
WAMSLEY, JK
LANGLAIS, PJ
FRIEDMANN, T
机构
[1] UNIV CALIF SAN DIEGO,SCH MED,CTR MOLEC GENET,DEPT NEUROSCI,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SCH MED,CTR MOLEC GENET,DEPT PEDIAT,LA JOLLA,CA 92093
[3] NEUROPSYCHIAT RES INST,FARGO,ND 58107
[4] NYU,MED CTR,NEUROCHEM RES LABS,NEW YORK,NY 10016
[5] VET ADM MED CTR,SAN DIEGO,CA 92161
[6] SAN DIEGO STATE UNIV,DEPT PSYCHOL,SAN DIEGO,CA 92161
来源
JOURNAL OF NEUROSCIENCE | 1994年 / 14卷 / 03期
关键词
HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; ANIMAL MODEL; NEUROGENETICS; NEUROCHEMISTRY;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have examined several aspects of neurotransmitter function in the brains of mice carrying a deletion mutation in the gene encoding the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). During the first 6 weeks of postnatal development, dopamine levels in whole-brain extracts from the mutant mice (HPRT(-)) failed to increase at rates comparable to normal animals, resulting in 40% lower dopamine levels throughout adulthood. Regional analysis in adult animals showed the caudoputamen to be the most severely affected region, with dopamine deficits of 48-64%. Dopamine levels in other regions were normal or less severely affected. The decrease in dopamine was accompanied by a decrease in tyrosine hydroxylase (TH) activity, the rate-limiting step in dopamine synthesis. Kinetic analysis of TH extracted from the caudoputamen of normal and HPRT(-) mice demonstrated a 45% decrease in V-max with an increased affinity for the tetrahydropterin cofactor in the mutants. Labeling of midbrain dopamine neurons using TH immunohistochemistry revealed no obvious deficits in the number of midbrain dopamine neurons, but quantitative autoradiographic studies revealed significant reductions in the binding of H-3-N-[1-(2-benzo(beta)thiophenyl)cyclohexyl]piperidine (H-3-BTCP) to dopamine uptake sites in the forebrain of the mutants. In contrast to these abnormalities of the dopamine systems in the mutant mice, other neurotransmitter systems appeared relatively unaffected. Norepinephrine, 5-HT, tryptophan hydroxylase, and glutamic acid decarboxylase were present at normal levels in the brains of the mutants. ChAT activity was slightly lower than normal in the caudoputamen of the mutant animals, but was normal in all other brain regions examined. These results indicate that HPRT deficiency is associated with a relatively specific deficit in basal ganglia dopamine systems that emerges during the first 2 months of postnatal development.
引用
收藏
页码:1164 / 1175
页数:12
相关论文
共 50 条
  • [1] Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch-Nyhan disease
    Hyland, K
    Kasim, S
    Egami, K
    Arnold, LA
    Jinnah, HA
    JOURNAL OF INHERITED METABOLIC DISEASE, 2004, 27 (02) : 165 - 178
  • [2] Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease
    Visser, JE
    Smith, DW
    Moy, SS
    Breese, GR
    Friedmann, T
    Rothstein, JD
    Jinnah, HA
    DEVELOPMENTAL BRAIN RESEARCH, 2002, 133 (02): : 127 - 139
  • [3] BRAIN PURINES IN A GENETIC MOUSE MODEL OF LESCH-NYHAN DISEASE
    JINNAH, HA
    PAGE, T
    FRIEDMANN, T
    JOURNAL OF NEUROCHEMISTRY, 1993, 60 (06) : 2036 - 2045
  • [4] Influence of age and strain on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease
    Jinnah, HA
    Jones, MD
    Wojcik, BE
    Rothstein, JD
    Hess, EJ
    Friedmann, T
    Breese, GR
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) : 225 - 229
  • [5] Dopamine function in Lesch-Nyhan disease
    Nyhan, WL
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 : 409 - 411
  • [6] HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch-Nyhan disease
    Witteveen, J. S.
    Loopstok, S. R.
    Ballesteros, L. Luque
    Boonstra, A.
    van Bakel, N. H. M.
    van Boekel, W. H. P.
    Martens, G. J. M.
    Visser, J. E.
    Kolk, S. M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (06)
  • [7] GENETIC EPIDEMIOLOGY OF LESCH-NYHAN DISEASE
    MORTON, NE
    LALOUEL, JM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1977, 29 (03) : 304 - 307
  • [8] A Golgi study of neuronal architecture in a genetic mouse model for Lesch-Nyhan disease
    Mikolaenko, I
    Rao, LM
    Roberts, RC
    Kolb, B
    Jinnah, HA
    NEUROBIOLOGY OF DISEASE, 2005, 20 (02) : 479 - 490
  • [9] A COMBINED GENETIC AND BIOCHEMICAL MOUSE MODEL FOR LESCH-NYHAN SYNDROME
    MCWHIR, J
    WU, CL
    MELTON, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 244 - 244
  • [10] SIGNIFICANCE OF DEFICIENCY STATE IN LESCH-NYHAN DISEASE
    GHADIMI, H
    BHALLA, CK
    KIRCHENB.DM
    ACTA PAEDIATRICA SCANDINAVICA, 1970, 59 (03): : 233 - &